Sarepta Therapeutics, Inc. (SRPT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8036071004
Sarepta Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.20 bn USD |
| Gross profit | 2.17 bn USD |
| Operating income | -699.78 m USD |
| EBIT | -771.13 m USD |
| Net income | -713.41 m USD |
| Diluted EPS – continuing operations | -7.13 USD |
Full history since 1995, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
More stocks
- Colt CZ Group SE (CZG.PR)
- ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
- Siltronic (WAF.DE)
- IDT CORP (IDT)
- Wuhu Token Sciences (300088.SZ)
- Taiflex Scientific Co Ltd (8039.TW)
- Shenglan Technology Co Ltd (300843.SZ)
- Absci Corp (ABSI)
- Monadelphous Group Ltd (MND.AX)
- Uwc Bhd (5292.KL)
- TRINITY INDUSTRIES INC (TRN)
- Malaysian Pacific Industries (3867.KL)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.